Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

P10914

- IRF1_HUMAN

UniProt

P10914 - IRF1_HUMAN

(max 400 entries)x

Your basket is currently empty.

Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)

Protein

Interferon regulatory factor 1

Gene

IRF1

Organism
Homo sapiens (Human)
Status
Reviewed - Annotation score: 5 out of 5- Experimental evidence at protein leveli

Functioni

Transcriptional regulator which displays a remarkable functional diversity in the regulation of cellular responses. These include the regulation of IFN and IFN-inducible genes, host response to viral and bacterial infections, regulation of many genes expressed during hematopoiesis, inflammation, immune responses and cell proliferation and differentiation, regulation of the cell cycle and induction of growth arrest and programmed cell death following DNA damage. Stimulates both innate and acquired immune responses through the activation of specific target genes and can act as a transcriptional activator and repressor regulating target genes by binding to an interferon-stimulated response element (ISRE) in their promoters. Its target genes for transcriptional activation activity include: genes involved in anti-viral response, such as IFN-alpha/beta, DDX58/RIG-I, TNFSF10/TRAIL, OAS1/2, PIAS1/GBP, EIF2AK2/PKR and RSAD2/viperin; antibacterial response, such as NOS2/INOS; anti-proliferative response, such as p53/TP53, LOX and CDKN1A; apoptosis, such as BBC3/PUMA, CASP1, CASP7 and CASP8; immune response, such as IL7, IL12A/B and IL15, PTGS2/COX2 and CYBB; DNA damage responses and DNA repair, such as POLQ/POLH; MHC class I expression, such as TAP1, PSMB9/LMP2, PSME1/PA28A, PSME2/PA28B and B2M and MHC class II expression, such as CIITA. Represses genes involved in anti-proliferative response, such as BIRC5/survivin, CCNB1, CCNE1, CDK1, CDK2 and CDK4 and in immune response, such as FOXP3, IL4, ANXA2 and TLR4. Stimulates p53/TP53-dependent transcription through enhanced recruitment of EP300 leading to increased acetylation of p53/TP53. Plays an important role in immune response directly affecting NK maturation and activity, macrophage production of IL12, Th1 development and maturation of CD8+ T-cells. Also implicated in the differentiation and maturation of dendritic cells and in the suppression of regulatory T (Treg) cells development. Acts as a tumor suppressor and plays a role not only in antagonism of tumor cell growth but also in stimulating an immune response against tumor cells.12 Publications

Enzyme regulationi

Activated by MYD88.By similarity

Regions

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
DNA bindingi5 – 113109IRF tryptophan pentad repeatPROSITE-ProRule annotationAdd
BLAST

GO - Molecular functioni

  1. DNA binding Source: UniProtKB
  2. RNA polymerase II core promoter proximal region sequence-specific DNA binding Source: BHF-UCL
  3. sequence-specific DNA binding transcription factor activity Source: Ensembl

GO - Biological processi

  1. apoptotic process Source: UniProtKB
  2. blood coagulation Source: Reactome
  3. CD8-positive, alpha-beta T cell differentiation Source: Ensembl
  4. cell cycle arrest Source: UniProtKB
  5. cellular response to interferon-beta Source: BHF-UCL
  6. cellular response to mechanical stimulus Source: UniProtKB
  7. cytokine-mediated signaling pathway Source: Reactome
  8. defense response to virus Source: UniProtKB
  9. interferon-gamma-mediated signaling pathway Source: UniProtKB
  10. negative regulation of cell proliferation Source: UniProtKB
  11. negative regulation of regulatory T cell differentiation Source: UniProtKB
  12. negative regulation of transcription, DNA-templated Source: UniProtKB
  13. positive regulation of interferon-beta production Source: UniProtKB
  14. positive regulation of interleukin-12 biosynthetic process Source: Ensembl
  15. positive regulation of transcription, DNA-templated Source: UniProtKB
  16. positive regulation of transcription from RNA polymerase II promoter Source: Ensembl
  17. positive regulation of type I interferon production Source: UniProtKB
  18. regulation of adaptive immune response Source: UniProtKB
  19. regulation of CD8-positive, alpha-beta T cell proliferation Source: UniProtKB
  20. regulation of cell cycle Source: UniProtKB
  21. regulation of innate immune response Source: UniProtKB
  22. regulation of MyD88-dependent toll-like receptor signaling pathway Source: UniProtKB
  23. transcription from RNA polymerase II promoter Source: ProtInc
  24. type I interferon signaling pathway Source: Reactome
Complete GO annotation...

Keywords - Molecular functioni

Activator, Repressor

Keywords - Biological processi

Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation

Keywords - Ligandi

DNA-binding

Enzyme and pathway databases

ReactomeiREACT_24938. TRAF6 mediated IRF7 activation.
REACT_24970. Factors involved in megakaryocyte development and platelet production.
REACT_25078. Interferon gamma signaling.
REACT_25162. Interferon alpha/beta signaling.
SignaLinkiP10914.

Names & Taxonomyi

Protein namesi
Recommended name:
Interferon regulatory factor 1
Short name:
IRF-1
Gene namesi
Name:IRF1
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
ProteomesiUP000005640: Chromosome 5

Organism-specific databases

HGNCiHGNC:6116. IRF1.

Subcellular locationi

Nucleus. Cytoplasm
Note: MYD88-associated IRF1 migrates into the nucleus more efficiently than non-MYD88-associated IRF1.

GO - Cellular componenti

  1. cytoplasm Source: UniProtKB
  2. cytosol Source: Reactome
  3. nuclear chromatin Source: BHF-UCL
  4. nucleoplasm Source: Reactome
  5. nucleus Source: UniProtKB
Complete GO annotation...

Keywords - Cellular componenti

Cytoplasm, Nucleus

Pathology & Biotechi

Involvement in diseasei

Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease.2 Publications
Note: Disease susceptibility is associated with variations affecting the gene represented in this entry.
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti8 – 81M → L in GASC; somatic mutation; produces a protein with markedly reduced transcriptional activity but unaltered DNA-binding activity. 1 Publication
VAR_065134
Natural varianti11 – 111W → R in GASC; the mutation abolishes DNA binding and transactivating activities. 1 Publication
VAR_065135

Mutagenesis

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Mutagenesisi78 – 781K → R: Loss of acetylation. Partial loss of DNA-binding and transcriptional activity. 1 Publication
Mutagenesisi275 – 2751K → R: Some loss of sumoylation. Partial inhibition of acetylation and activity. Abolishes sumoylation, diminished ubiquitination, higher resistance to degradation, and increased apoptotic activity; when associated with R-299. 1 Publication
Mutagenesisi299 – 2991K → R: Large loss of sumoylation. Abolishes sumoylation, diminished ubiquitination, higher resistance to degradation, and increased apoptotic activity; when associated with R-275. 1 Publication

Keywords - Diseasei

Disease mutation, Tumor suppressor

Organism-specific databases

MIMi613659. phenotype.
PharmGKBiPA29915.

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Chaini1 – 325325Interferon regulatory factor 1PRO_0000154545Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Modified residuei78 – 781N6-acetyllysine1 Publication
Cross-linki275 – 275Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
Cross-linki299 – 299Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)

Post-translational modificationi

Phosphorylated by CK2 and this positively regulates its activity.1 Publication
Sumoylation represses the transcriptional activity and displays enhanced resistance to protein degradation. Inactivates the tumor suppressor activity. Elevated levels in tumor cells. Major site is Lys-275. Sumoylation is enhanced by PIAS3 (By similarity). Desumoylated by SENP1 in tumor cells and appears to compete with ubiquitination on C-terminal sites.By similarity1 Publication
Ubiquitinated. Appears to compete with sumoylation on C-terminal sites.1 Publication

Keywords - PTMi

Acetylation, Isopeptide bond, Phosphoprotein, Ubl conjugation

Proteomic databases

MaxQBiP10914.
PaxDbiP10914.
PRIDEiP10914.

PTM databases

PhosphoSiteiP10914.

Expressioni

Inductioni

By viruses and interferon (IFN).

Gene expression databases

BgeeiP10914.
CleanExiHS_IRF1.
ExpressionAtlasiP10914. baseline and differential.
GenevestigatoriP10914.

Organism-specific databases

HPAiCAB011662.

Interactioni

Subunit structurei

Monomer. Homodimer. Interacts with MYD88 and PIAS3 (By similarity). Interacts with EP300.By similarity1 Publication

Binary interactionsi

WithEntry#Exp.IntActNotes
E7P031293EBI-1055781,EBI-866453From a different organism.

Protein-protein interaction databases

BioGridi109867. 36 interactions.
DIPiDIP-40988N.
IntActiP10914. 4 interactions.
MINTiMINT-123145.
STRINGi9606.ENSP00000245414.

Structurei

3D structure databases

ProteinModelPortaliP10914.
SMRiP10914. Positions 7-111.
ModBaseiSearch...
MobiDBiSearch...

Family & Domainsi

Sequence similaritiesi

Belongs to the IRF family.PROSITE-ProRule annotation
Contains 1 IRF tryptophan pentad repeat DNA-binding domain.PROSITE-ProRule annotation

Phylogenomic databases

eggNOGiNOG42582.
HOGENOMiHOG000037937.
HOVERGENiHBG003455.
InParanoidiP10914.
KOiK09444.
OMAiCKEEPEV.
OrthoDBiEOG72ZCFD.
PhylomeDBiP10914.
TreeFamiTF328512.

Family and domain databases

Gene3Di1.10.10.10. 1 hit.
InterProiIPR017431. Interferon_reg_fac-1/2.
IPR019817. Interferon_reg_fac_CS.
IPR001346. Interferon_reg_fact_DNA-bd_dom.
IPR011991. WHTH_DNA-bd_dom.
[Graphical view]
PfamiPF00605. IRF. 1 hit.
[Graphical view]
PIRSFiPIRSF038196. IFN_RF1/2. 1 hit.
PRINTSiPR00267. INTFRNREGFCT.
SMARTiSM00348. IRF. 1 hit.
[Graphical view]
PROSITEiPS00601. IRF_1. 1 hit.
PS51507. IRF_2. 1 hit.
[Graphical view]

Sequencei

Sequence statusi: Complete.

P10914-1 [UniParc]FASTAAdd to Basket

« Hide

        10         20         30         40         50
MPITRMRMRP WLEMQINSNQ IPGLIWINKE EMIFQIPWKH AAKHGWDINK
60 70 80 90 100
DACLFRSWAI HTGRYKAGEK EPDPKTWKAN FRCAMNSLPD IEEVKDQSRN
110 120 130 140 150
KGSSAVRVYR MLPPLTKNQR KERKSKSSRD AKSKAKRKSC GDSSPDTFSD
160 170 180 190 200
GLSSSTLPDD HSSYTVPGYM QDLEVEQALT PALSPCAVSS TLPDWHIPVE
210 220 230 240 250
VVPDSTSDLY NFQVSPMPST SEATTDEDEE GKLPEDIMKL LEQSEWQPTN
260 270 280 290 300
VDGKGYLLNE PGVQPTSVYG DFSCKEEPEI DSPGGDIGLS LQRVFTDLKN
310 320
MDATWLDSLL TPVRLPSIQA IPCAP
Length:325
Mass (Da):36,502
Last modified:April 16, 2002 - v2
Checksum:i2E06245A212D1541
GO

Experimental Info

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sequence conflicti5 – 51R → W no nucleotide entry (PubMed:2726461)Curated
Sequence conflicti5 – 51R → W no nucleotide entry (PubMed:3409321)Curated
Sequence conflicti34 – 352FQ → LE no nucleotide entry (PubMed:2726461)Curated
Sequence conflicti34 – 352FQ → LE no nucleotide entry (PubMed:3409321)Curated
Sequence conflicti220 – 2201T → I no nucleotide entry (PubMed:2726461)Curated
Sequence conflicti220 – 2201T → I no nucleotide entry (PubMed:3409321)Curated

Natural variant

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti8 – 81M → L in GASC; somatic mutation; produces a protein with markedly reduced transcriptional activity but unaltered DNA-binding activity. 1 Publication
VAR_065134
Natural varianti11 – 111W → R in GASC; the mutation abolishes DNA binding and transactivating activities. 1 Publication
VAR_065135

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
X14454 mRNA. Translation: CAA32624.1.
L05072 Genomic DNA. Translation: AAA36043.1.
BT019756 mRNA. Translation: AAV38561.1.
BC009483 mRNA. Translation: AAH09483.1.
CCDSiCCDS4155.1.
PIRiB31595.
I52998.
RefSeqiNP_002189.1. NM_002198.2.
UniGeneiHs.436061.

Genome annotation databases

EnsembliENST00000245414; ENSP00000245414; ENSG00000125347.
ENST00000405885; ENSP00000384406; ENSG00000125347.
GeneIDi3659.
KEGGihsa:3659.
UCSCiuc003kxa.2. human.

Polymorphism databases

DMDMi20178295.

Cross-referencesi

Web resourcesi

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
X14454 mRNA. Translation: CAA32624.1 .
L05072 Genomic DNA. Translation: AAA36043.1 .
BT019756 mRNA. Translation: AAV38561.1 .
BC009483 mRNA. Translation: AAH09483.1 .
CCDSi CCDS4155.1.
PIRi B31595.
I52998.
RefSeqi NP_002189.1. NM_002198.2.
UniGenei Hs.436061.

3D structure databases

ProteinModelPortali P10914.
SMRi P10914. Positions 7-111.
ModBasei Search...
MobiDBi Search...

Protein-protein interaction databases

BioGridi 109867. 36 interactions.
DIPi DIP-40988N.
IntActi P10914. 4 interactions.
MINTi MINT-123145.
STRINGi 9606.ENSP00000245414.

PTM databases

PhosphoSitei P10914.

Polymorphism databases

DMDMi 20178295.

Proteomic databases

MaxQBi P10914.
PaxDbi P10914.
PRIDEi P10914.

Protocols and materials databases

DNASUi 3659.
Structural Biology Knowledgebase Search...

Genome annotation databases

Ensembli ENST00000245414 ; ENSP00000245414 ; ENSG00000125347 .
ENST00000405885 ; ENSP00000384406 ; ENSG00000125347 .
GeneIDi 3659.
KEGGi hsa:3659.
UCSCi uc003kxa.2. human.

Organism-specific databases

CTDi 3659.
GeneCardsi GC05M131817.
H-InvDB HIX0200727.
HGNCi HGNC:6116. IRF1.
HPAi CAB011662.
MIMi 147575. gene.
613659. phenotype.
neXtProti NX_P10914.
PharmGKBi PA29915.
GenAtlasi Search...

Phylogenomic databases

eggNOGi NOG42582.
HOGENOMi HOG000037937.
HOVERGENi HBG003455.
InParanoidi P10914.
KOi K09444.
OMAi CKEEPEV.
OrthoDBi EOG72ZCFD.
PhylomeDBi P10914.
TreeFami TF328512.

Enzyme and pathway databases

Reactomei REACT_24938. TRAF6 mediated IRF7 activation.
REACT_24970. Factors involved in megakaryocyte development and platelet production.
REACT_25078. Interferon gamma signaling.
REACT_25162. Interferon alpha/beta signaling.
SignaLinki P10914.

Miscellaneous databases

GeneWikii IRF1.
GenomeRNAii 3659.
NextBioi 14311.
PROi P10914.
SOURCEi Search...

Gene expression databases

Bgeei P10914.
CleanExi HS_IRF1.
ExpressionAtlasi P10914. baseline and differential.
Genevestigatori P10914.

Family and domain databases

Gene3Di 1.10.10.10. 1 hit.
InterProi IPR017431. Interferon_reg_fac-1/2.
IPR019817. Interferon_reg_fac_CS.
IPR001346. Interferon_reg_fact_DNA-bd_dom.
IPR011991. WHTH_DNA-bd_dom.
[Graphical view ]
Pfami PF00605. IRF. 1 hit.
[Graphical view ]
PIRSFi PIRSF038196. IFN_RF1/2. 1 hit.
PRINTSi PR00267. INTFRNREGFCT.
SMARTi SM00348. IRF. 1 hit.
[Graphical view ]
PROSITEi PS00601. IRF_1. 1 hit.
PS51507. IRF_2. 1 hit.
[Graphical view ]
ProtoNeti Search...

Publicationsi

« Hide 'large scale' publications
  1. Cited for: NUCLEOTIDE SEQUENCE [MRNA].
  2. "Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements."
    Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi T.
    Cell 54:903-913(1988) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
  3. "Human interferon regulatory factor 1: intron-exon organization."
    Cha Y., Sims S.H., Romine M.F., Kaufmann M., Deisseroth A.B.
    DNA Cell Biol. 11:605-611(1992) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Tissue: Placenta.
  4. "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
    Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A.
    Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
  5. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Tissue: Pancreas.
  6. "Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia."
    Willman C.L., Sever C.E., Pallavicini M.G., Harada H., Tanaka N., Slovak M.L., Yamamoto H., Harada K., Meeker T.C., List A.F., Taniguchi T.
    Science 259:968-971(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN LEUKEMIAS.
  7. "A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity."
    Lin R., Hiscott J.
    Mol. Cell. Biochem. 191:169-180(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION.
  8. "IRF family of transcription factors as regulators of host defense."
    Taniguchi T., Ogasawara K., Takaoka A., Tanaka N.
    Annu. Rev. Immunol. 19:623-655(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON FUNCTION.
  9. Cited for: REVIEW ON FUNCTION.
  10. Cited for: REVIEW ON FUNCTION.
  11. "Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells."
    Oshima S., Nakamura T., Namiki S., Okada E., Tsuchiya K., Okamoto R., Yamazaki M., Yokota T., Aida M., Yamaguchi Y., Kanai T., Handa H., Watanabe M.
    Mol. Cell. Biol. 24:6298-6310(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
  12. "Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53."
    Dornan D., Eckert M., Wallace M., Shimizu H., Ramsay E., Hupp T.R., Ball K.L.
    Mol. Cell. Biol. 24:10083-10098(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH EP300.
  13. "IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors."
    Honda K., Taniguchi T.
    Nat. Rev. Immunol. 6:644-658(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON FUNCTION.
  14. "Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression."
    Su Z.Z., Sarkar D., Emdad L., Barral P.M., Fisher P.B.
    J. Cell. Physiol. 213:502-510(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
  15. "RNA interference of interferon regulatory factor-1 gene expression in THP-1 cell line leads to Toll-like receptor-4 overexpression/activation as well as up-modulation of annexin-II."
    Maratheftis C.I., Giannouli S., Spachidou M.P., Panayotou G., Voulgarelis M.
    Neoplasia 9:1012-1020(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
  16. "Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis."
    Park J., Kim K., Lee E.-J., Seo Y.-J., Lim S.-N., Park K., Rho S.B., Lee S.-H., Lee J.-H.
    Proc. Natl. Acad. Sci. U.S.A. 104:17028-17033(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: SUMOYLATION AT LYS-275 AND LYS-299, UBIQUITINATION AT LYS-275 AND LYS-299, FUNCTION, MUTAGENESIS OF LYS-275 AND LYS-299.
  17. "IRF-1 promotes apoptosis in p53-damaged basal-type human mammary epithelial cells: a model for early basal-type mammary carcinogenesis."
    Bowie M.L., Ibarra C., Seewalt V.L.
    Adv. Exp. Med. Biol. 617:367-374(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
  18. "IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression."
    Fragale A., Gabriele L., Stellacci E., Borghi P., Perrotti E., Ilari R., Lanciotti A., Remoli A.L., Venditti M., Belardelli F., Battistini A.
    J. Immunol. 181:1673-1682(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
  19. "Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages."
    Huang Y., Walstrom A., Zhang L., Zhao Y., Cui M., Ye L., Zheng J.C.
    PLoS ONE 4:E5397-E5397(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
  20. "Regulation of immunity and oncogenesis by the IRF transcription factor family."
    Savitsky D., Tamura T., Yanai H., Taniguchi T.
    Cancer Immunol. Immunother. 59:489-510(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON FUNCTION.
  21. "IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells."
    Gao J., Senthil M., Ren B., Yan J., Xing Q., Yu J., Zhang L., Yim J.H.
    Cell Death Differ. 17:699-709(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
  22. "Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes."
    Muto V., Stellacci E., Lamberti A.G., Perrotti E., Carrabba A., Matera G., Sgarbanti M., Battistini A., Liberto M.C., Foca A.
    J. Virol. 85:5070-5080(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
  23. "Interferon regulatory factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells."
    Armstrong M.J., Stang M.T., Liu Y., Gao J., Ren B., Zuckerbraun B.S., Mahidhara R.S., Xing Q., Pizzoferrato E., Yim J.H.
    Cancer Lett. 319:56-65(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
  24. "Interferon regulatory factor 1 transactivates the expression of human DNA polymerase eta in response to the carcinogen N-methyl-N'-nitro-N-nitrosoguanidine."
    Qi H., Zhu H., Lou M., Fan Y., Liu H., Shen J., Li Z., Lv X., Shan J., Zhu L., Chin Y.E., Shao J.
    J. Biol. Chem. 287:12622-12633(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, ACETYLATION AT LYS-78, MUTAGENESIS OF LYS-78.
  25. "Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer."
    Nozawa H., Oda E., Ueda S., Tamura G., Maesawa C., Muto T., Taniguchi T., Tanaka N.
    Int. J. Cancer 77:522-527(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANT GASC LEU-8, CHARACTERIZATION OF VARIANT GASC LEU-8.
  26. "Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding."
    Eason D.D., Shepherd A.T., Blanck G.
    Biochim. Biophys. Acta 1446:140-144(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANT GASC ARG-11.

Entry informationi

Entry nameiIRF1_HUMAN
AccessioniPrimary (citable) accession number: P10914
Secondary accession number(s): Q96GG7
Entry historyi
Integrated into UniProtKB/Swiss-Prot: July 1, 1989
Last sequence update: April 16, 2002
Last modified: November 26, 2014
This is version 142 of the entry and version 2 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Miscellaneous

Deletion or rearrangement of IRF1 are found in preleukemic myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML).

Keywords - Technical termi

Complete proteome, Reference proteome

Documents

  1. Human chromosome 5
    Human chromosome 5: entries, gene names and cross-references to MIM
  2. Human entries with polymorphisms or disease mutations
    List of human entries with polymorphisms or disease mutations
  3. Human polymorphisms and disease mutations
    Index of human polymorphisms and disease mutations
  4. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  5. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3